Nexalin Technology Commences Sales of Second-Generation Neurostimulation Device in Oman
Thursday, 14 March 2024, 12:48
Nexalin Technology: Gen-2 Neurostimulation Device Sales
Nexalin Technology has recently introduced its second-generation neurostimulation device in Oman, targeting substance abuse disorder treatment.
Key Highlights:
- Advanced Technology: The gen-2 device offers enhanced features for improved treatment outcomes.
- Market Expansion: Nexalin Technology is expanding its market presence with the launch in Oman.
- Treatment Innovation: Patients can now benefit from innovative solutions for substance abuse disorder.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.